October is National Breast Cancer Awareness Month, a time to reflect on the staggering statistic that around 700,000 individuals in the U.S. will be diagnosed with breast cancer this year, with up to 10% of these cases linked to hereditary gene mutations. Thankfully, with advancements in both fertility treatments and genetic testing, couples now have the opportunity to mitigate the risk of passing these genetic issues onto their children.
Recent developments have led to expanded options for screening over 280 recessive gene mutations, including conditions like cystic fibrosis, Tay-Sachs disease, and spinal muscular atrophy. Those at risk for dominant gene mutations, such as those related to breast cancer, can also have tailored testing. Identifying any genetic diseases allows couples to consider IVF with preimplantation genetic testing for monogenic defects (PGT-M), helping reduce the chance of passing on these mutations.
Ava Greene: A Voice for Change
In a proactive move to educate patients about these options and fertility preservation before cancer treatment, a new partnership has emerged with Ava Greene, a breast cancer previvor and passionate advocate for women’s health. Having lost her mother to breast cancer at a young age, Ava deeply understands the struggle of navigating life without maternal guidance. “Growing up without my mom was tough, especially when it came to life’s big moments,” she shares. “I want to inspire others to turn their challenges into motivation.”
Ava’s journey has been marked by significant decisions, including undergoing a prophylactic mastectomy after learning of her own genetic risks. She has since become a role model, using her platform to encourage preventive healthcare among women. Her #SelfCheckChallenge on social media promotes the importance of early breast cancer detection through monthly self-exams.
Embarking on the IVF Journey
Currently, Ava is embarking on her IVF journey, working with Dr. Ben Thompson at a local fertility clinic. She plans to utilize PGT-M to minimize the risk of passing on inherited conditions. “At first, the whole process felt overwhelming,” Ava admits. “But the supportive team reassured me that I wasn’t alone in this.”
“This initiative is a wonderful opportunity to assist Ava and her husband in their family-building journey. For individuals like her, genetic testing provides a safe method to reduce the likelihood of passing on genetic mutations,” Dr. Thompson explains. Ava is sharing her IVF experience, hoping to demystify the process for others and remind women to advocate for their health.
Support for Cancer Patients
Though Ava is currently cancer-free, specialized teams are available to assist patients with cancer in preserving their fertility, ensuring a smooth transition into treatment. This dedicated support includes guidance on financing and the medical procedures involved.
Staying Informed
For those interested in exploring fertility preservation and treatment options, it’s essential to stay informed. Check out this article on Kawasaki disease in children for a deeper understanding of related health issues. If you’re looking for ways to boost fertility, this resource on fertility boosters for men is worth exploring. For comprehensive insights on pregnancy and home insemination, Healthline is an excellent source.
Conclusion
In summary, Ava Greene’s advocacy and personal journey highlight the importance of genetic testing and fertility preservation for women at risk of breast cancer. By sharing her story, she aims to empower others to take charge of their reproductive health and make informed decisions.